GP

Girish P Mirji

Active Director Designated Partner DIN 10757987
DIN 10757987 First appointment Aug 2024 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Girish P Mirji

Data last updated:

Girish P Mirji is a Designated Partner at Arx Biosciences Llp (since 2024) and Designated Partner at Celestia Power And Engineering Llp (since 2024). The companies operate in Biotechnology.

DIN 10757987
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 28 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Oct 20242024Active
Designated Partner28 Aug 20242024Active

Board colleagues of Girish P Mirji

Directorship timeline

Open interactive timeline →
Arx Biosciences Llp
Celestia Power And Engineering Llp
Premium access

Shareholding and investment profile for Girish P Mirji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish P Mirji

Girish P Mirji currently holds 2 directorships: Arx Biosciences Llp (Designated Partner, since 21 Oct 2024); Celestia Power And Engineering Llp (Designated Partner, since 28 Aug 2024).

Girish P Mirji was first appointed on 28 Aug 2024 as Designated Partner at Celestia Power And Engineering Llp.

The current boards of Girish P Mirji's companies include Shailesh Gangadar Rao Deshpande (Arx Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available